Tag: Chemotherapy
Pembrolizumab Not Better Than PTX for Advanced Gastric Cancer
Survival no better with second-line pembrolizumab than paclitaxel for gastric, gastro-esophageal cancer
ASCO: Overall Survival Up for African-American Men With mCRPC
Improved survival versus Caucasian men treated with docetaxel/prednisone, DP-containing regimen
ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery
Worse Survival for BRCA Germline Mutation Carriers in Pancreatic CA
For BRCA germline mutation carriers, better survival seen with platinum-based chemotherapy
ICU Mortality Similar for Patients With Hematologic CA ± Chemo
However, patients with hematologic cancer receiving chemotherapy have longer ICU, hospital stays
Peripheral Neuropathy Common in Childhood Cancer Survivors
Long-term neurotoxicity was more frequently seen with cisplatin than with vinca alkaloids
Nodal Response to Pre-Op Tx Tied to Survival in Esophageal Cancer
Survival benefit of nodal response maintained among patients with nodal, but not primary response
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
Leukemia, and Its Treatment, May Pose Neurocognitive Risks
Cerebrospinal fluid biomarkers may identify those at greater risk for poor neuro-related outcomes
3, 6 Month Adjuvant CAPOX Equally Effective for Colon Cancer
FOLFOX therapy for 6 months had higher disease-free survival rate compared to 3 months of treatment
